跳至主要内容
临床试验/NCT03057925
NCT03057925Unknown不适用

Ultrasound-guided Percutaneous Microwave Ablation for Benign Thyroid Nodules

Wenjun Wu1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2017年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
Change of the thyroid nodule volume assessed by ultrasonography after treatment vs simple clinical observation

研究概览

简要总结

Percutaneous microwave ablation(MWA) was reported as an effective modality for the management of thyroid nodules(TNs). This study aims to validate MWA as a feasible approach for patients with TNs for whom surgery is contraindicated or refused. Two groups of subjects with TNs(one group to treat with MWA and the other group to receive regular ultrasonic follow-up without any treatment) will be evaluated in term of TN volume, ultrasonic image and clinical symptoms.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •age>18 years
  • •benign thyroid nodules(TYP 2)
  • •solid or predominantly solid(colloid component<30%)large (>3.0ml) thyroid nodules
  • •refusal and/or inefficacy of surgery

排除标准

  • •pregnancy
  • •malignant or suspicious thyroid nodules

研究组 & 干预措施

Group A

Experimental

MWA Percutaneous Microwave Ablation intervention procedure: Ultrasound-guided Percutaneous Microwave Ablation

干预措施: Microwave Ablation (Device)

Group B

No Intervention

untreated no treatment; regular ultrasonic image follow-up

结局指标

主要结局

Change of the thyroid nodule volume assessed by ultrasonography after treatment vs simple clinical observation

时间窗: From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months

Change of the thyroid nodule volume assessed by using ultrasonography, the volume reduction ratio(VRR) was calculated by the equation: VRR%=\[(initial volume-final volume)\*100\]/initial volume

次要结局

  • Improved score on TN-related symptoms(From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months)
  • Improved cosmetic grading score(From time to treatment until 12 months. Time point evaluations at 1,3,6,12 months)

研究者

发起方
Wenjun Wu
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Wenjun Wu

associate chief physician

First Affiliated Hospital of Wenzhou Medical University

研究点 (1)

Loading locations...

相似试验